Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
Corvus Pharmaceuticals initiated its Phase 1b clinical trial of soquelitinib for the treatment of patients with hidradenitis suppurativa.